Clinical Trial Update: Post Transplant Donor Lymphocyte Infusion [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for post-transplant donor lymphocyte infusion; the study is terminated with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Leukemia Lymphocytic Acute
• Leukemia Lymphocytic Chronic
• Leukemia Myeloid Chronic
• Lymphomas
• Multiple Myeloma
• Myelodysplastic Syndrome

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Leukemia, Myeloid, Chronic, Lymphomas | Phase 2 | Status: TERMINATED | Results posted: 2017-07-11